Search - tctmd.com

Displaying 841 - 860 of 989

Sort: Relevancy | Date

Presentation NY Valves 2024

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Presenter: Joao L. Cavalcante

June 05, 2024

Presentation NY Valves 2024

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

Presenter: Sabina Kumar

June 05, 2024

Presentation NY Valves 2024

The Lifetime Management of Aortic Stenosis: The Unmet Needs

Presenter: Sammy Elmariah

June 05, 2024

Presentation NY Valves 2024

The Lifetime Management of Aortic Stenosis: A Heart Team Perspective

Presenter: Michael J. Reardon

June 05, 2024

Presentation NY Valves 2024

Impact of Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes in Patients Undergoing Noncardiac Surgery

Presenter: Kitae Kim

June 05, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Richard Tanner

June 05, 2024

Presentation NY Valves 2024

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

June 05, 2024

Presentation NY Valves 2024

What About the Patient's Voice? Shared Decision-making Tools

Presenter: Megan Coylewright

June 05, 2024

Presentation NY Valves 2024

Pre-Existing Thoracic Aortic Aneurysm is Associated with Type A Aortic Dissections After Transcatheter Aortic Valve Replacement

Presenter: Tyler Bauer

June 05, 2024

Presentation NY Valves 2024

Impact of Atherosclerotic Disease Extent on Clinical Outcomes in Female Patients Undergoing TAVI: A Report From the WIN-TAVI Registry

Presenter: Benjamin Bay

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… The Ross Procedure Is the Best Option

Presenter: Ismail El-Hamamsy

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… TAVR First Is the Best Option!

Presenter: Mayra Guerrero

June 05, 2024

Presentation NY Valves 2024

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

Presenter: Eduardo A. Arias

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Presenter: Bo Yang

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Presenter: Shreeya Shabari

June 05, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

Presenter: Nirat Beohar

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Never Use a Mechanical Valve

Presenter: Anelechi Anyanwu

June 05, 2024

Presentation NY Valves 2024

3 Reasons Why… I Would Recommend a Mechanical Valve

Presenter: Michael J. Mack

June 05, 2024

Presentation NY Valves 2024

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Presenter: Masaaki Nakase

June 05, 2024

Presentation NY Valves 2024

Case Presentation: A Healthy 55 Year-Old With Severe AS

Presenter: Michael I. Brener

June 05, 2024

Advertisement

Risk Stratification for Aortic Regurgitation: Echo or CMR?

Chronic Kidney Disease and In-hospital Outcomes in TAVR Patients

The Lifetime Management of Aortic Stenosis: The Unmet Needs

The Lifetime Management of Aortic Stenosis: A Heart Team Perspective

Impact of Surgical or Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis on Perioperative Outcomes in Patients Undergoing Noncardiac Surgery

Case Presentation

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

What About the Patient's Voice? Shared Decision-making Tools

Pre-Existing Thoracic Aortic Aneurysm is Associated with Type A Aortic Dissections After Transcatheter Aortic Valve Replacement

Impact of Atherosclerotic Disease Extent on Clinical Outcomes in Female Patients Undergoing TAVI: A Report From the WIN-TAVI Registry

3 Reasons Why… The Ross Procedure Is the Best Option

3 Reasons Why… TAVR First Is the Best Option!

Prophylactic VA-ECMO for TAVI Using Self-Expandable Valves in Patients With Cardiogenic Shock and a Left Ventricular Ejection Fraction Below 30%

3 Reasons Why… I Always Consider Root Enlargement for Lifetime Management

Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study

Transcatheter Aortic Valve Replacement in Patients Admitted With Aortic Stenosis and Acute Heart Failure: Insights From the STS-TVT Registry

3 Reasons Why… I Would Never Use a Mechanical Valve

3 Reasons Why… I Would Recommend a Mechanical Valve

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Case Presentation: A Healthy 55 Year-Old With Severe AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content